These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6166569)

  • 21. [Prevention and therapy of herpesvirus infections].
    Abb J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation and antiviral effect of acyclovir in cells infected with a varicella-like simian virus.
    Fyfe JA; Biron KK; McKee SA; Kelly CM; Elion GB; Soike KF
    Am J Med; 1982 Jul; 73(1A):58-61. PubMed ID: 6285734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of human leukocyte interferon on vaccinia-and herpes virus-infected cell cultures and monkey corneas.
    Neumann-Haefelin D; Sundmacher R; Sauter B; Karges HE; Manthey KF
    Infect Immun; 1975 Jul; 12(1):148-55. PubMed ID: 166924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture.
    Boyd MR; Bacon TH; Sutton D; Cole M
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1238-42. PubMed ID: 3631945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-(2-Chloroethyl)-2'-deoxyuridine: a potent and selective inhibitor of herpes viruses in vitro and in vivo.
    Rosenwirth B; Griengl H; Wanek E; De Clercq E
    Antiviral Res; 1985; Suppl 1():20-8. PubMed ID: 3002256
    [No Abstract]   [Full Text] [Related]  

  • 26. Synergistic antiviral activities of acyclovir and recombinant human leukocyte (alpha) interferon on feline herpesvirus replication.
    Weiss RC
    Am J Vet Res; 1989 Oct; 50(10):1672-7. PubMed ID: 2552872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of acyclovir combined with other antiviral agents on human cytomegalovirus.
    Spector SA; Tyndall M; Kelley E
    Am J Med; 1982 Jul; 73(1A):36-9. PubMed ID: 6179416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovir.
    Spector T; Harrington JA; Morrison RW; Lambe CU; Nelson DJ; Averett DR; Biron K; Furman PA
    Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1051-5. PubMed ID: 2536930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Reusser P; Cordonnier C; Einsele H; Engelhard D; Link D; Locasciulli A; Ljungman P
    Bone Marrow Transplant; 1996 May; 17(5):813-7. PubMed ID: 8733703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mechanisms of antiviral resistance among the herpesvirus group].
    Reina J
    Enferm Infecc Microbiol Clin; 1997; 15(6):329-34. PubMed ID: 9376408
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of acyclovir on the proliferation of human fibroblasts and peripheral blood mononuclear cells.
    Levin MJ; Leary PL; Arbeit RD
    Antimicrob Agents Chemother; 1980 Jun; 17(6):947-53. PubMed ID: 6157361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging therapies for herpes viral infections (types 1 - 8).
    Chakrabarty A; Pang KR; Wu JJ; Narvaez J; Rauser M; Huang DB; Beutner KR; Tyring SK
    Expert Opin Emerg Drugs; 2004 Nov; 9(2):237-56. PubMed ID: 15571482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined effects of flavonoids and acyclovir against herpesviruses in cell cultures.
    Mucsi I; Gyulai Z; Béládi I
    Acta Microbiol Hung; 1992; 39(2):137-47. PubMed ID: 1339152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir.
    Standring-Cox R; Bacon TH; Howard BA
    J Virol Methods; 1996 Jan; 56(1):3-11. PubMed ID: 8690764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The in vitro activity of acyclovir and related compounds against cytomegalovirus infections.
    Tyms AS; Scamans EM; Naim HM
    J Antimicrob Chemother; 1981 Jul; 8(1):65-72. PubMed ID: 6265430
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of human cytomegalovirus replication by 9-(1,3-dihydroxy-2-propoxymethyl)guanine alone and in combination with human interferons.
    Rasmussen L; Chen PT; Mullenax JG; Merigan TC
    Antimicrob Agents Chemother; 1984 Oct; 26(4):441-5. PubMed ID: 6097163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses.
    Lowe DM; Alderton WK; Ellis MR; Parmar V; Miller WH; Roberts GB; Fyfe JA; Gaillard R; Ertl P; Snowden W
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1802-8. PubMed ID: 7486922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the effects of arabinosyladenine, arabinosylhypoxanthine, and arabinosyladenine 5'-monophosphate against herpes simplex virus, varicella-zoster virus, and cytomegalovirus with their effects on cellular deoxyribonucleic acid synthesis.
    Gephart JF; Lerner AM
    Antimicrob Agents Chemother; 1981 Jan; 19(1):170-8. PubMed ID: 6166244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of plaque formation of herpes simplex virus (HSV) and varicella-zoster virus (VZV) by subinhibitory dose of acyclovir (ACV).
    Shiraki K; Miyaki C; Namazue J; Yamanishi K; Takahashi M
    Acta Virol; 1989 Dec; 33(6):565-8. PubMed ID: 2576598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. History, pharmacokinetics, and pharmacology of acyclovir.
    King DH
    J Am Acad Dermatol; 1988 Jan; 18(1 Pt 2):176-9. PubMed ID: 2828440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.